Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Hike in Gold Price Slows, Still Near Record Highs

Published 07/28/2020, 11:37 PM
Updated 07/28/2020, 11:43 PM
© Reuters.

By Bryan Wong

Investing.com- Gold hovered around record highs on Wednesday morning in Asia as the US dollar remained weak and debate continued in the U.S. over the next COVID-related stimulus package.

Gold futures gained 0.05% to $1,945.60 by 11:40 PM ET (4:40 AM GMT), lower than the $1,968.00 level hit on Tuesday, suggesting that the relentless climb in the price of the yellow metal may be coming to an end.

Investors are also looking to the U.S. Federal Reserve's meeting, scheduled for later in the day, for clues on the U.S. economy's health.

However, some experts remain optimistic.

"We think the current momentum in the next few months will cross the $2,000 an ounce mark. The key question is how much does the rally increase after that," Vivek Dhar, mining and energy commodities analyst at the Commonwealth Bank of Australia (OTC:CMWAY), told CNBC.

The U.S. Dollar Index was marginally higher on Wednesday, but has been generally dropping for the last month.

Among the factors slowing down the hike in gold prices are hopes of rapid development of a vaccine,  on the other hand the lack of progress on a stimulus package in the U.S. supported gold prices.

The U.S. Congress has not yet reached a deal over a new COVID-19 stimulus package. U.S. President Donald Trump sent mixed signals after telling reporters Monday that there were aspects of the proposed package he did not like while Senate Majority Leader Mitch McConnell also said he opposed “non-germane” elements in the plan, such as a provision to fund a new FBI building that the White House had insisted upon and is not pandemic related.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Still, the beginning on Monday of the world’s biggest trial to date of a COVID-19 vaccine by the National Institutes of Health and Moderna (NASDAQ:MRNA) Inc. has given hope to many of speedier return to economic normalcy.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.